# E-DRUG: dipyrone / metamizol **URL:** \ **Category:** e-drug\ **Created:** [April 29, 1997, 10:45am UTC](https://talk.edrugplus.org/t/e-drug-dipyrone-metamizol/696 "1997-04-29T10:45:28Z")\ **Posts on this page:** 1\ **Page:** 1
**Author:** ![myhr](https://avatars.discourse-cdn.com/v4/letter/m/f07891/32.png) [@myhr](https://talk.edrugplus.org/u/myhr)\ **Post date:** [April 29, 1997, 10:45am UTC](https://talk.edrugplus.org/t/e-drug-dipyrone-metamizol/696/1 "1997-04-29T10:45:28Z")
E-DRUG: dipyrone / metamizol (cont) ----------------------------------- Metamizol/dipyrone/analgin/noraminophenazonum etc. was recently registered in Sweden (kind of reintroduction as it formerly existed at least in one preparation called Palerol comp. from Sandoz and which was used for treatment of biliary colic and colic caused by kidney stones as far as I remember). The drug now registered, Novalgin from Hoechst, comes in tablets and as injection. Indications: Short-term treatment of acute moderate to severe pain caused by tissue damage, e.g. after surgical procedures and colic, e.g. biliary and urinary. With Sweden being a EU-member, it is to be expected that metamizole will reappear in more European countries. Metamizole is extensively used in East Europe. In Mongolia, which I visited recently, in addition to commerially available preparations, the pharmacies were producing Analgin solutions in large quantities and selling it without prescription. Metamizole has also been part of drug donations by e.g. MSF, Spain. They claim to use it as an alternative to opiates which cannot be included in donations (or so they say). Regards Kirsten Myhr Ms Kirsten Myhr, MScPharm, MPH Bygdoy Alle 58B 0265 Oslo Norway Tel: +47 22 56 05 85 (h) Fax: +47 22 24 90 17 (w) Tel: +47 22 24 90 39 (w) E-mail: myhr@online.no or (w): kirsten.myhr@helsetilsynet.dep.telemax.no -- Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'. Mail administrative requests to `majordomo@usa.healthnet.org'. For additional assistance, send mail to: `owner-e-drug@usa.healthnet.org'.